.png){kind=icon}
.png){kind=icon}
Return
Nanotechnology Meets Immunotherapy: Crosstalks Against Cancer
.png){kind=icon}
OA
AI
N
A
R
F
H
DOI：10.1002/iid3.70437.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The convergence of nanotechnology and immunotherapy has ushered in a transformative era in cancer treatment, offering new strategies to overcome pharmacokinetic limitations and immune evasion associated with conventional therapies. While immunotherapy, spanning checkpoint inhibitors, adoptive cell transfer, and cancer vaccines, has revolutionized oncology, its efficacy remains constrained by the immunosuppressive tumor microenvironment (TME), off-target toxicity, and poor biodistribution of therapeutic agents.
Keywords:
cancer immunotherapy
combination therapy
nanoparticles
nanotechnology
tumor microenvironment
tumor microenvironment
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
I
IF:
0
Papers:
83
Citations:
0
View more organizations